Opioid receptors: distinct roles in mood disorders
暂无分享,去创建一个
[1] T. Vanderah,et al. The delta opioid receptor , 2013 .
[2] I. Sora,et al. Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. , 2013, The international journal of neuropsychopharmacology.
[3] B. Kieffer,et al. Ligand‐directed signalling within the opioid receptor family , 2012, British journal of pharmacology.
[4] R. Maldonado,et al. Influence of δ-Opioid Receptors in the Behavioral Effects of Nicotine , 2012, Neuropsychopharmacology.
[5] B. Kieffer,et al. The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice. , 2012, European journal of pharmacology.
[6] Shanna L Resendez,et al. κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance , 2012, The Journal of Neuroscience.
[7] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[8] K. Lutfy,et al. The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide. , 2012, European journal of pharmacology.
[9] N. Eisenberger. The pain of social disconnection: examining the shared neural underpinnings of physical and social pain , 2012, Nature Reviews Neuroscience.
[10] Andreas Meyer-Lindenberg,et al. Neural mechanisms of social risk for psychiatric disorders , 2012, Nature Neuroscience.
[11] J. Pintar,et al. Loss of the mu opioid receptor on different genetic backgrounds leads to increased bromodeoxyuridine labeling in the dentate gyrus only after repeated injection , 2012, Neuroscience.
[12] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[13] R. Stevens,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[14] D. David,et al. Functional Status of Somatodendritic Serotonin 1A Autoreceptor after Long-Term Treatment with Fluoxetine in a Mouse Model of Anxiety/Depression Based on Repeated Corticosterone Administration , 2012, Molecular Pharmacology.
[15] A. Der-Avakian,et al. The neurobiology of anhedonia and other reward-related deficits , 2012, Trends in Neurosciences.
[16] I. Tkáč,et al. Postnatal morphine administration alters hippocampal development in rats , 2012, Journal of neuroscience research.
[17] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[18] C. Nemeroff,et al. Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal , 2011, Neuropsychopharmacology.
[19] R. Bodnar. Endogenous opiates and behavior: 2010 , 2011, Peptides.
[20] B. Kieffer,et al. Sequential and opposing alterations of 5-HT1A receptor function during withdrawal from chronic morphine , 2011, European Neuropsychopharmacology.
[21] H. Tejeda,et al. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders , 2011, Cellular and Molecular Life Sciences.
[22] K. Wada,et al. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions , 2011, Behavioural Brain Research.
[23] I. Sora,et al. Decreased response to social defeat stress in μ-opioid-receptor knockout mice , 2011, Pharmacology Biochemistry and Behavior.
[24] K. Befort,et al. The delta opioid receptor: an evolving target for the treatment of brain disorders. , 2011, Trends in pharmacological sciences.
[25] R. Lefkowitz,et al. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. , 2011, Trends in biochemical sciences.
[26] Garet P Lahvis,et al. Social influences on morphine-conditioned place preference in adolescent BALB/cJ and C57BL/6J mice , 2011, Psychopharmacology.
[27] Julia C. Lemos,et al. Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction , 2011, Neuron.
[28] Jason S. Snyder,et al. Adult hippocampal neurogenesis buffers stress responses and depressive behavior , 2011, Nature.
[29] R. Hen,et al. Experience Dictates Stem Cell Fate in the Adult Hippocampus , 2011, Neuron.
[30] C. Zarate,et al. Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments , 2011, Depression and anxiety.
[31] R. Maldonado,et al. Deletion of the δ Opioid Receptor Gene Impairs Place Conditioning But Preserves Morphine Reinforcement , 2011, Biological Psychiatry.
[32] B. Klausz,et al. Changes in adaptability following perinatal morphine exposure in juvenile and adult rats. , 2011, European journal of pharmacology.
[33] A. Siracusano,et al. Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients , 2011, Social neuroscience.
[34] E. Costello,et al. Child μ-Opioid Receptor Gene Variant Influences Parent–Child Relations , 2011, Neuropsychopharmacology.
[35] Qiang Chen,et al. The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice , 2011, Neuroscience Letters.
[36] B. Kieffer,et al. Impaired Emotional-Like Behavior and Serotonergic Function During Protracted Abstinence from Chronic Morphine , 2011, Biological Psychiatry.
[37] E. Nestler,et al. Linking molecules to mood: new insight into the biology of depression. , 2010, The American journal of psychiatry.
[38] L. Vanderschuren,et al. The pleasures of play: pharmacological insights into social reward mechanisms. , 2010, Trends in pharmacological sciences.
[39] E. Susser,et al. Early Life Programming and Neurodevelopmental Disorders , 2010, Biological Psychiatry.
[40] Robert A Koeppe,et al. Dysregulation of regional endogenous opioid function in borderline personality disorder. , 2010, The American journal of psychiatry.
[41] M. Messaoudi,et al. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. , 2010, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[42] S. Mague,et al. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. , 2010, Drug and alcohol dependence.
[43] E. Castrén,et al. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity , 2010, Developmental neurobiology.
[44] G. Koob,et al. The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse , 2010, Psychopharmacology.
[45] Allison T. Knoll,et al. Dynorphin, stress, and depression , 2010, Brain Research.
[46] M. Bruchas,et al. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors , 2010, Brain Research.
[47] R. Přikryl,et al. A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia , 2010, Journal of Molecular Neuroscience.
[48] R. Palmiter,et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking , 2009, Proceedings of the National Academy of Sciences.
[49] K. Befort,et al. Reward processing by the opioid system in the brain. , 2009, Physiological reviews.
[50] R. Lanius,et al. The role of β-endorphin in the pathophysiology of major depression , 2009, Neuropeptides.
[51] J. Micó,et al. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. , 2009, The international journal of neuropsychopharmacology.
[52] Baldwin M. Way,et al. Variation in the μ-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection , 2009, Proceedings of the National Academy of Sciences.
[53] J. Micó,et al. Opiates as antidepressants. , 2009, Current pharmaceutical design.
[54] V. Chefer,et al. Augmentation of Morphine-Induced Sensitization but Reduction in Morphine Tolerance and Reward in Delta-Opioid Receptor Knockout Mice , 2009, Neuropsychopharmacology.
[55] M. Olmstead,et al. Mu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task , 2009, PloS one.
[56] P. Wellman,et al. Different affective response to opioid withdrawal in adolescent and adult mice. , 2009, Life sciences.
[57] V. Chefer,et al. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. , 2008, CNS & neurological disorders drug targets.
[58] L. Granero,et al. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens , 2008, Neuropharmacology.
[59] Peter L Tenore,et al. Psychotherapeutic Benefits of Opioid Agonist Therapy , 2008, Journal of addictive diseases.
[60] B. Kieffer,et al. Brain Regional Fos Expression Elicited by the Activation of μ- but not δ-Opioid Receptors of the Ventral Tegmental Area: Evidence for an Implication of the Ventral Thalamus in Opiate Reward , 2008, Neuropsychopharmacology.
[61] J. Kamei,et al. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model , 2008, Brain Research.
[62] David Goldman,et al. Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates , 2008, Proceedings of the National Academy of Sciences.
[63] B. Roques,et al. Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours , 2008, Psychopharmacology.
[64] S. Salvadori,et al. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist , 2008, Peptides.
[65] M. Meaney,et al. Maternal separation leads to persistent reductions in pain sensitivity in female rats. , 2007, The journal of pain : official journal of the American Pain Society.
[66] Garet P Lahvis,et al. Social reward among juvenile mice , 2007, Genes, brain, and behavior.
[67] S. Watson,et al. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. , 2007, European journal of pharmacology.
[68] R. Gereau,et al. Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward , 2007, Proceedings of the National Academy of Sciences.
[69] Dan J Stein,et al. Opioids: From Physical Pain to the Pain of Social Isolation , 2007, CNS Spectrums.
[70] A. Lichtman,et al. NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. , 2007, European journal of pharmacology.
[71] R. Hen,et al. Neurodevelopmental origins of depressive disorders. , 2007, Current opinion in pharmacology.
[72] G. Aston-Jones,et al. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal , 2007, Behavioural Brain Research.
[73] I. Sora,et al. Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons , 2007, Neuroscience.
[74] Robert A Koeppe,et al. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. , 2006, Archives of general psychiatry.
[75] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[76] E. Nestler,et al. The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.
[77] Shuang Li,et al. Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System , 2006, Neuropsychopharmacology.
[78] S. Watson,et al. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. , 2006, European journal of pharmacology.
[79] S. Watson,et al. Endogenous opioids upregulate brain‐derived neurotrophic factor mRNA through δ‐ and µ‐opioid receptors independent of antidepressant‐like effects , 2006 .
[80] B. Sharp. Multiple opioid receptors on immune cells modulate intracellular signaling , 2006, Brain, Behavior, and Immunity.
[81] S. Watson,et al. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats , 2006, Brain Research.
[82] B. Roques,et al. Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment , 2005, Neuroscience.
[83] B. Roques,et al. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors , 2005, Neuroscience.
[84] J. Zubieta,et al. Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[85] E. Jutkiewicz,et al. Differential Behavioral Tolerance to the δ-Opioid Agonist SNC80 ([(+)-4-[(αR)-α-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[86] James L. Howard,et al. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats , 2005, Psychopharmacology.
[87] E. Jutkiewicz,et al. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats , 2005, Psychopharmacology.
[88] M. Collu,et al. Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice , 2005, Synapse.
[89] E. Nunes,et al. Treatment of depression in patients with opiate dependence , 2004, Biological Psychiatry.
[90] R. Kessler. The epidemiology of dual diagnosis , 2004, Biological Psychiatry.
[91] H. Loh,et al. Altered emotional behaviors and the expression of 5‐HT1A and M1 muscarinic receptors in μ‐opioid receptor knockout mice , 2004, Synapse.
[92] A. Cowan,et al. Buprenorphine: a unique drug with complex pharmacology. , 2004, Current neuropharmacology.
[93] Masaaki Iwata,et al. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects , 2004, Journal of neurochemistry.
[94] P. Escribá,et al. Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims , 2004, Neuropsychopharmacology.
[95] G. Gerra,et al. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. , 2004, Drug and alcohol dependence.
[96] B. Kieffer,et al. Deficit in Attachment Behavior in Mice Lacking the µ-Opioid Receptor Gene , 2004, Science.
[97] K. Befort,et al. Mu opioid receptor: a gateway to drug addiction , 2004, Current Opinion in Neurobiology.
[98] E. Jutkiewicz,et al. δ-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[99] S. Watson,et al. The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats , 2004, Neuropsychopharmacology.
[100] R. Koeppe,et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. , 2003, Archives of general psychiatry.
[101] E. Jutkiewicz,et al. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats , 2003, Behavioural pharmacology.
[102] Jaak Panksepp,et al. Feeling the Pain of Social Loss , 2003, Science.
[103] Philip S. Portoghese,et al. Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[104] P. Eriksson,et al. Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors , 2003, The European journal of neuroscience.
[105] Eric J. Nestler,et al. Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect , 2002, The Journal of Neuroscience.
[106] T. Robinson,et al. Widespread but regionally specific effects of experimenter‐ versus self‐administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats , 2002, Synapse.
[107] J. Micó,et al. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. , 2002, Life sciences.
[108] R. Tao,et al. GABAergic and Glutamatergic Afferents in the Dorsal Raphe Nucleus Mediate Morphine-Induced Increases in Serotonin Efflux in the Rat Central Nervous System , 2002, Journal of Pharmacology and Experimental Therapeutics.
[109] R. Tao,et al. Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System , 2002, Journal of Pharmacology and Experimental Therapeutics.
[110] E. Jutkiewicz,et al. Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats , 2002, Psychopharmacology.
[111] E. Jutkiewicz,et al. Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.
[112] C. Gaveriaux-Ruff,et al. Opioid receptor genes inactivated in mice: the highlights , 2002, Neuropeptides.
[113] Jamie Fong,et al. Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.
[114] V. Pickel,et al. Major coexpression of κ‐opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles , 2001, Synapse.
[115] N. Nishiyama,et al. Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test , 2001, Psychopharmacology.
[116] G. Koob,et al. Increased Ethanol Self‐Administration in δ‐Opioid Receptor Knockout Mice , 2001 .
[117] M. Kalinichev,et al. Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence , 2001, Psychopharmacology.
[118] M. Kalinichev,et al. Repeated neonatal maternal separation alters morphine-induced antinociception in male rats , 2001, Brain Research Bulletin.
[119] P. Song,et al. The involvement of glial cells in the development of morphine tolerance , 2001, Neuroscience Research.
[120] G. Aston-Jones,et al. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion , 2000, Nature.
[121] G. Aghajanian,et al. Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway , 1999, Neuroscience.
[122] R. Niesink,et al. Social behavior of juvenile rats after in utero exposure to morphine: dose–time–effect relationship , 1999, Neuropharmacology.
[123] W. Coryell,et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. , 1999, The American journal of psychiatry.
[124] Ian Kitchen,et al. Morphine treatment during juvenile isolation increases social activity and opioid peptides release in the adult rat , 1999, Brain Research.
[125] K. Grasing,et al. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal , 1998, Neuropharmacology.
[126] B. Roques,et al. Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. , 1998, European journal of pharmacology.
[127] Jerry M. Lewis,et al. For better or worse: interpersonal relationships and individual outcome. , 1998, The American journal of psychiatry.
[128] G. Koob,et al. Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.
[129] Shakti Sharma,et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. , 1997, Science.
[130] B. Roques,et al. Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats. , 1997, Neuroscience.
[131] B. M. Spruijt,et al. Prenatal exposure to morphine affects juvenile play behavior and adult social behavior in rats , 1996, Pharmacology Biochemistry and Behavior.
[132] H. Steiner,et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.
[133] A. Ornoy,et al. The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. , 1996, Child abuse & neglect.
[134] B. Roques,et al. Implication of endogenous opioid system in the learned helplessness model of depression , 1995, Pharmacology Biochemistry and Behavior.
[135] R. Tao,et al. Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain , 1995, Neuroscience.
[136] J. García-Sevilla,et al. Increased density of μ-opioid receptors in the postmortem brain of suicide victims , 1995, Brain Research.
[137] L. Vanderschuren,et al. μ- and κ-opioid receptor-meiated opioid effects on social play in juvenile rats , 1995 .
[138] C. Heyser,et al. Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone , 1994, Psychopharmacology.
[139] B. Roques,et al. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat , 1993, Biological Psychiatry.
[140] G. Gessa,et al. Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanis , 1993, Brain Research.
[141] M. M. de Cubas,et al. Children of methadone-dependent women: developmental outcomes. , 1993, The American journal of orthopsychiatry.
[142] Anat Biegon,et al. Regionally selective increases in μ opioid receptor density in the brains of suicide victims , 1990, Brain Research.
[143] S. Shelton,et al. Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation. , 1989, Science.
[144] J. Bowlby. Attachment and loss: retrospect and prospect. , 1982, The American journal of orthopsychiatry.
[145] A. Kastin,et al. Enkephalin and other peptides reduce passiveness , 1978, Pharmacology Biochemistry and Behavior.
[146] A. Markou,et al. Animal models and treatments for addiction and depression co-morbidity , 2009, Neurotoxicity Research.
[147] J. Tassin. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. , 2008, Biochemical pharmacology.
[148] B. Lebowitz,et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.
[149] A. Eisch,et al. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology , 2006, Hippocampus.
[150] E. Jutkiewicz,et al. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. , 2005, The Journal of pharmacology and experimental therapeutics.
[151] A. Eschalier,et al. Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats , 2005, Psychopharmacology.
[152] E. Jutkiewicz,et al. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. , 2004, The Journal of pharmacology and experimental therapeutics.
[153] J. Kamei,et al. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. , 2004, Journal of pharmacological sciences.
[154] A. Eschalier,et al. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice , 2004, Psychopharmacology.
[155] S. Watson,et al. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[156] P. Escribá,et al. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[157] Jaak Panksepp,et al. Neuroscience. Feeling the pain of social loss. , 2003, Science.
[158] E. Jutkiewicz,et al. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. , 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[159] G. Koob,et al. Increased ethanol self-administration in delta-opioid receptor knockout mice. , 2001, Alcoholism, clinical and experimental research.
[160] A. Dierich,et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. , 2000, Nature genetics.
[161] G. Ladd,et al. Peer relationships and social competence during early and middle childhood. , 1999, Annual review of psychology.
[162] L. Vanderschuren,et al. Mu- and kappa-opioid receptor-mediated opioid effects on social play in juvenile rats. , 1995, European journal of pharmacology.